Frontiers in Cardiovascular Medicine (Apr 2022)

Diastolic Plateau – Invasive Hemodynamic Marker of Adverse Outcome Among Left Ventricular Assist Device Patients

  • Avishay Grupper,
  • Avishay Grupper,
  • Afek Kodesh,
  • Jacob Lavee,
  • Jacob Lavee,
  • Paul Fefer,
  • Paul Fefer,
  • Israel M. Barbash,
  • Israel M. Barbash,
  • Dan Elian,
  • Dan Elian,
  • Alexander Kogan,
  • Alexander Kogan,
  • Avi Morgan,
  • Avi Morgan,
  • Amit Segev,
  • Amit Segev,
  • Elad Maor,
  • Elad Maor

DOI
https://doi.org/10.3389/fcvm.2022.847205
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundDiastolic plateau is an invasive hemodynamic marker of impaired right ventricular (RV) diastolic filling. The purpose of the current analysis was to evaluate the prognostic importance of this sign in left ventricular assist device (LVAD) patients.MethodsThe analysis included all LVAD patients who received continuous-flow LVAD (HeartMate 3) at the Sheba medical center and underwent right heart catheterization (RHC) during follow up post-LVAD surgery. Patients were dichotomized into 2 mutually exclusive groups based on a plateau duration cutoff of 55% of diastole. The primary end point of the current analysis was the composite of death, heart transplantation, or increase in diuretic dosage in a 12-month follow-up period post-RHC.ResultsStudy cohort included 59 LVAD patients with a mean age of 57 (IQR 54–66) of whom 48 (81%) were males. RHC was performed at 303 ± 36 days after LVAD surgery. Patients with and without diastolic plateau had similar clinical, echocardiographic, and hemodynamic parameters. Kaplan–Meier survival analysis showed that the cumulative probability of event at 1 year was 65 ± 49% vs. 21 ± 42% for primary outcomes among patients with and without diastolic plateau (p Log rank < 0.05 for both). A multivariate model with adjustment for age, INTERMACS score and ischemic cardiomyopathy consistently showed that patients with diastolic plateau were 4 times more likely to meet the study composite end point (HR = 4.35, 95% CI 1.75–10.83, p = 0.002).ConclusionDiastolic plateau during RHC is a marker of adverse outcome among LVAD patients.

Keywords